
Tharimmune makes a pivot into digital assets, raises approximately $540 million via a private placement
Tharimmune, Inc., a clinical-stage biotechnology company traditionally focused on developing therapies for rare immune, inflammatory, and oncologic...

Stablecoin Giant Tether Backs $459M Bitcoin Buy for Twenty One Capital
Stablecoin giant Tether has once again made headlines with a bold move to support Bitcoin adoption. On May 9, Tether purchased 4,812.2 Bitcoin wort...